Given the increasing frequency of Hematologic Malignancy, especially in an aging population, as well as the complexities of individual clinic presentation, there is a need to provide an opportunity for Oncologists, Hematologists and Oncology Nurses to engage in a thoughtful examination and discussion with experts in various hematologic cancers. There is also emerging data about the biology of these cancers that underlies modern optimal management of patients with these disorders. The expansion of patient care options in nearly all of these disorders makes decision making more complex. This two and a half-day symposium has been designed by experts in the field of hematologic malignancies and affords the conferee specialized educational tracks for both physicians and nurses providing the opportunity to learn about the most recent advances in the treatment of bone marrow transplant, multiple myeloma, lymphoma and leukemia. Updates on improved curative and palliative treatments and evolving molecular and immunologically-based system therapies, as well as important, completed or ongoing clinical trials, will be profiled and discussed.
Date:March 11, 2016
Time: 09:30 AM - 10:30 AM (PT)
Location:Radiology Conference Room
Who should attend:Otolaryngologists, Head and Neck Surgeons, Practitioners in Head and Neck Oncology (Radiation Oncology, Medical Oncology), Related Specialties (Pathologists, Radiologists, Neurosurgeons, Reconstructive Surgeons, Dentists, Nurses, Clinical Social Work, Psychiatry, Rehabilitative specialists), Fellows, Residents, Students, Scientists
CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM
R.S.V.P.: Please Contact Siniabell Rodriguez Ext. 65546